The findings are being presented at the American Society of Clinical Oncology’s annual meeting. Researchers studied 340 patients who had completed cancer treatment or were being treated for cancer at one of 40
This result may reflect the fact that this test is frequently pursued in clinical patients presenting with inconclusive findings and/or comorbidities. Intermediate orexin levels found in 8 % of the samples (100 % <= 40 years). Although most of the patients tested were female (62.2%) and most...
We sought to investigate the clinical utility of the TSO500 kit in patients with solid tumors (ST) by determining its ability to detect a target for an FDA-approved drug in tumor type (FDA-in-TT), and in other tumor type (FDA-in-OTT). The TSO500 kit which is commercially offered by...